209 related articles for article (PubMed ID: 31600177)
1. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
[TBL] [Abstract][Full Text] [Related]
2. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
Worrell HI; Sciallis AP; Skala SL
Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390
[TBL] [Abstract][Full Text] [Related]
3. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
[TBL] [Abstract][Full Text] [Related]
5. Significance of stromal markers in atypical polypoid adenomyoma.
Travaglino A; Raffone A; Gencarelli A; Zullo F; Di Spiezio Sardo A; Insabato L
Pathol Res Pract; 2020 Nov; 216(11):153133. PubMed ID: 32823231
[TBL] [Abstract][Full Text] [Related]
6. Atypical polypoid adenomyoma of the endometrium: diagnosis and treatment. A case report.
Domeniconi L; Amadori A; Maniglio P; Saragoni L
Pathologica; 2020 Dec; 112(4):214-218. PubMed ID: 33393525
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
[TBL] [Abstract][Full Text] [Related]
8. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study.
Soslow RA; Chung MH; Rouse RV; Hendrickson MR; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):209-16. PubMed ID: 8811381
[TBL] [Abstract][Full Text] [Related]
9. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features.
Lu B; Yu M; Shi H; Chen Q
Pathol Res Pract; 2019 Apr; 215(4):766-771. PubMed ID: 30661903
[TBL] [Abstract][Full Text] [Related]
10. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
11. A case of endometrial carcinoma arising in a 36-year-old woman with uterine atypical polypoid adenomyoma (APA).
Bakalianou K; Salakos N; Iavazzo C; Paltoglou G; Papadias K; Kondi-Pafiti A
Eur J Gynaecol Oncol; 2008; 29(3):298-9. PubMed ID: 18592801
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
[TBL] [Abstract][Full Text] [Related]
13. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
14. Frequent β-catenin gene mutations in atypical polypoid adenomyoma of the uterus.
Takahashi H; Yoshida T; Matsumoto T; Kameda Y; Takano Y; Tazo Y; Inoue H; Saegusa M
Hum Pathol; 2014 Jan; 45(1):33-40. PubMed ID: 24182564
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
16. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
17. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
Ramalingam P; Masand RP; Euscher ED; Malpica A
Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
[TBL] [Abstract][Full Text] [Related]
18. Endometrioid Endometrial Carcinoma With Spindle Cells-Aberrant p16 and p53 Expression.
Sonawane S; Elfituri O; Zhang Y; Yordan E; Ree N
Int J Surg Pathol; 2019 Apr; 27(2):203-207. PubMed ID: 29953305
[TBL] [Abstract][Full Text] [Related]
19. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
20. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
